Medicine & Life Sciences
Erlotinib Hydrochloride
49%
Microtubules
37%
Non-Small Cell Lung Carcinoma
34%
Tubulin
13%
Cyclin B1
11%
isonicotinamide
8%
calcein AM
6%
Aurora Kinase B
6%
polo-like kinase 1
6%
Aurora Kinase A
6%
Therapeutics
6%
Vinca Alkaloids
6%
CDC2 Protein Kinase
6%
G2 Phase Cell Cycle Checkpoints
5%
Rhodamine 123
5%
Taxoids
5%
Neoplasms
5%
Poly(ADP-ribose) Polymerases
5%
Cell Line
5%
Protein-Serine-Threonine Kinases
4%
A549 Cells
4%
ATP Binding Cassette Transporter, Subfamily B, Member 1
4%
Polymerization
4%
Growth
4%
Cell Division
4%
Intravenous Administration
4%
Caspase 3
3%
In Vitro Techniques
3%
Fluorescent Antibody Technique
3%
Coloring Agents
3%
Cell Survival
3%
Down-Regulation
3%